492
Views
5
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy for opioid addiction in community corrections

, , , , , , & show all
Pages 117-135 | Received 05 Jul 2018, Accepted 11 Sep 2018, Published online: 06 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Cayley Russell, Michelle Pang, Frishta Nafeh, Shanna Farrell Macdonald, Dena Derkzen, Jürgen Rehm & Benedikt Fischer. (2022) Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada. International Journal of Qualitative Studies on Health and Well-being 17:1.
Read now
Kelly E. Dunn. (2018) Promoting a comprehensive understanding of the opioid epidemic. International Review of Psychiatry 30:5, pages 89-90.
Read now

Articles from other publishers (3)

Nicole Milano, Jamey J. Lister & Grant Victor. (2023) Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid use disorder. The American Journal on Addictions 32:4, pages 352-359.
Crossref
Cayley Russell, Frishta Nafeh, Michelle Pang, Shanna Farrell MacDonald, Dena Derkzen, Jürgen Rehm & Benedikt Fischer. (2022) Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study. BMC Public Health 22:1.
Crossref
Cayley Russell, Michelle Pang, Frishta Nafeh, Shanna Farrell MacDonald, Dena Derkzen, Jürgen Rehm & Benedikt Fischer. (2022) Applying the socio-ecological model to understand community reintegration experiences among individuals on opioid agonist treatment (OAT) released from federal incarceration in Ontario, Canada. SSM - Qualitative Research in Health 2, pages 100083.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.